Search
for

    Sort by

    Research 421–450 of 487

    1. Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment Cancer · 2025 · 3 citations
    2. Antiseizure Medication-Induced Alopecia: A Literature Review Medicines · 2023 · 3 citations
    3. Sacituzumab Govitecan-Hziy (Trodelvy™) Oncology Times · 2021 · 3 citations
    4. Update on Outcome Measures for Pediatric Systemic Lupus Erythematosus Arthritis Care & Research · 2020 · 3 citations
    5. Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study Journal of Dermatological Treatment · 2026 · 2 citations
    6. Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review Cosmetics · 2023 · 2 citations
    7. Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports Phytotherapy Research · 2023 · 2 citations
    8. Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review 2023 · 2 citations
    9. Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome F&S Reports · 2023 · 2 citations
    10. Muscle weakness of the lower limbs after epidural anesthesia in a pregnant woman with undiscovered systemic lupus erythematosus Chinese Medical Journal · 2020 · 2 citations
    11. Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors Journal of clinical and investigative dermatology · 2014 · 2 citations
    12. Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study Journal of Community Medicine & Public Health · 2024 · 1 citations
    13. Long- COVID and general health status in hospitalized COVID-19 survivors Scientific Reports · 2023 · 1 citations
    14. Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study 2023 · 1 citations
    15. Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report IDCases · 2023 · 1 citations
    16. Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19) Anais Brasileiros de Dermatologia · 2022 · 1 citations
    17. Prevalence and predictors of persistent post-COVID-19 symptoms JAMMI · 2022 · 1 citations
    18. The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy Journal of Cancer Therapy · 2022 · 1 citations
    19. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer Frontiers in Oncology · 2021 · 1 citations
    20. Hydrogels: current biomedical applications and future directions Molecular Biomedicine · 2026
    21. Severe Lichen Planus Pigmentosus Inversus in an Elderly Female Following Intra-Articular Injections of Homeopathic Substances Dermato · 2026
    22. Patient-Reported Flare Symptoms Following COVID-19 Vaccination in Systemic Lupus Erythematosus Cureus · 2026
    23. Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system Medicine · 2026
    24. Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study Clinical and Experimental Dermatology · 2026
    25. Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches Annals of Medicine · 2026
    26. Evolution and mechanistic insights of platelet-derived products in temporomandibular joint regeneration Frontiers in Cell and Developmental Biology · 2026
    27. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    28. Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management Diseases · 2025
    29. Adverse events of the thyroid peroxidase inhibitor methimazole in the treatment of hyperthyroidism: a comprehensive analysis from the first quarter of 2004 to the first quarter of 2025 Frontiers in Endocrinology · 2025
    30. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025